AROBELLA ULTRASOUND MIST THERAPY

Ultrasound MIST Therapy

Ultrasound MIST therapy is a cutting-edge, non-invasive treatment designed to accelerate wound healing and improve patient outcomes. By utilizing low-frequency ultrasound waves delivered through a saline mist, this therapy effectively reduces bacteria, disrupts biofilms, and stimulates cellular activity to promote natural healing. Ideal for chronic and hard-to-heal wounds, MIST therapy enhances circulation, decreases inflammation, and supports tissue regeneration without causing pain or discomfort. With proven clinical results, it is an invaluable tool in modern wound care management.

QOUSTIC WOUND THERAPY SYSTEM™ DEVICE

For wounds, burns and hard & soft tissues

OVERVIEW

Arobella Medical, LLC is an innovative company that designs, develops, and produces medical devices that use ultrasound technology for wound healing. These devices are primarily used in the treatment of chronic and complex wounds, such as diabetic ulcers, pressure sores, venous ulcers, and surgical wounds. Ultrasound therapy promotes faster tissue repair, reduces inflammation, and stimulates circulation, which can significantly accelerate the healing process.

Choosing an Ultrasound Wound Treatment Device is an important decision if you’re looking for effective, reliable, and cutting-edge solutions for wound healing. Here are several reasons why partnering with the right manufacturer can benefit you:

Quality and Certification
Device Features and Technology
Experience and Reputation
Customer Support and Training

This process is directed for single (1) treatment, and total recommended treatment shall be no more than three (3) times per week; typically treatment regimen is approximately two (2) weeks or more, depending on the size and nature/condition of the treated area as well as other subject dependent factors, but may be prescribed longer on the order of a physician.

This product has been cleared by the FDA for sale in the United States. Cleared indications for use (K062544)

Selective dissection and fragmentation of tissue, wound debridement (acute and chronic wounds, burns, diseased or necrotic tissue), and cleansing irrigation of the site for the removal of debris, exudates, fragments, and other matter.

This product has been cleared by the FDA for sale in the United States. Cleared indications for use (K131096)

Selective and non-selective dissection and fragmentation of soft and/or hard tissue
Surgical, excisional or sharp-edge wound debridement (acute and chronic wounds, burns) for the removal of nonviable tissue including but not limited to diseased tissue, necrotic tissue, slough and eschar, fibrin, tissue exudates, bacteria and other matter
Site cleansing irrigation and lavage of wound tissue (acute and chronic wounds, burns, diseased or necrotic tissue)
Contact and/or non-contact maintenance debridement for the removal of debris, exudates, fragments, bacteria, slough, fibrin, excised or fragmented tissue, and other matter
Preparing the wound bed for graft or other subsequent procedures using contact and/or non-contact techniques to achieve wound debridement
It is prescribed for patient population of any age with one or more wounds and/or that may also exhibit Diabetes Mellitus (DM)

Ideal for

Wound Management
Treating specific types of wounds including:
Diabetic foot ulcers
Pressure ulcers
Venous Insufficiency Ulcers
Arterial Wounds
Compromised Surgical Wounds
Burns
Osteomyelitis
Fistulas
Infected, Eczematous, Ulcerated or Devitalized Skin

The Qoustic Wound Therapy System™ can be used with the following irrigation (lavage) fluids:

Sterile 0.9% saline (which is widely available for purchase from medical suppliers)
Sterile de-ionized water
Vashe™ Wound Cleanser solution (which is produced from PuriCore’s Vashe™ Generator)
Other solutions approved for wound therapy or debridement

Generator power source: 90-264~, 2.5A, 50-60Hz
Converter Power Output: <140 watts
Amplitude: 0 – 75 μm
Frequency: 35kHz (±2kHz)
Weight:
Generator: 13.5 lbs (6.1kg) [AR1000B];
Handheld Applicator: 13.5 oz (0.4kg) [AR1000] / 11.5 oz (0.3kg) [AR1000D]
Dimensions:
Generator: 15.50 in (W) x 14.25 in (D) x 5.25 in (H);
Handheld Applicator: 9 in x 1.4 in (Ø)

The following case studies have been completed and presented to demonstrate the advantages of Ultrasound-Assisted Wound (UAW) Therapy and its positive effect on the wound debridement process:

Case Presentations: Low-frequency Ultrasound Therapy in the Management of Severe Burn Wounds (0.9 MB)
March 1, 2010
Kazu Suzuki, DPM CWS / Joel Aronowitz, MD
Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA

In Vitro Activity of the Arobella Acoustic Curette Against Planktonic and Biofilm Bacteria (0.9 MB)
Melissa J. Jacobson, Kerryl E. Piper, Steven J. Kavros, James M. Steckelbert
& Robin Patel
Mayo Clinic College of Medicine, Rochester MN USA
Presented at ASM May 17-21, 2009, Philadelphia, PA – Posted here on July 22, 2009

Effects of Low Frequency Ultrasound delivered via the Qoustic Wound Therapy System on Neuroblastoma (SHSY-5Y) Viability and Morphology (2.7 MB)
Teresa Conner-Kerr, Ph.D., PT, CWS, CLT, et al,
Dept. of Physical Therapy, Winston-Salem State University, Winston-Salem, NC
Presented at SAWC – April 25-29, 2009 – Dallas, TX
Posted here on April 30, 2009

Low-Frequency Ultrasound Therapy of Lower Extremity Wounds Significantly Increases the Peri-wound Skin Perfusion Pressure (0.7 MB)
March 21, 2009
Kazu Suzuki DPM CWS1, Lisa Cowan MS-I, PhD2, and Joel Aronowitz MD1
(1) Tower Wound Care Center, Cedars-Sinai Medical Towers, Los Angeles, CA
(2) Keck School of Medicine, University of Southern California, Los Angeles, CA

Case Presentations: Low-frequency Ultrasound Therapy for the Treatment of Painful and Difficult-to-Treat Leg Ulcers (0.7 MB)
March 21, 2009
Kazu Suzuki, DPM CWS / Joel Aronowitz, MD
Tower Wound Care Center, Cedars-Sinai Medical Towers, Los Angeles, CA